total new process (patent delivered)
thin films (biomaterials) of controlled stiffness presenting bioactive proteins
enable high content studies of cell signaling
enable high content imaging
CancerAddressing target audiences and expressing needs
- Grants and Subsidies
- Use of research Infrastructure
- Collaboration
collaborations with researchers or industries that want to test growth factors delivered via biomaterials
cell signaling studies
specific targeting of cellular receptors
- Public or private funding institutions
- Other Actors who can help us fulfil our market potential
- Research and Technology Organisations
R&D, Technology and Innovation aspects
current stage: several POC obtained on different growth factors and extracellular matrix proteins (BMPs, fibronectin)
POC obtained on different self-assembled materials :layer-by-layer assembly and streptabivin-biotin based platforms
next step :
-that cell biologists use our bioactive-coated plates to conduct their own signaling studies (POC on growth factors for specific applications)
-establish collaborations with companies working in the field of bone morphogenetic proteins, growth derived factor 5 and Transforming growth factors , and other growth factors (Epidermal growth factor, fibroblast growth factor, vascular endothelial growth factor)
- test drugs to target signaling pathways
- can be applied to any type of growth factor or active proteins
- could be applied to other types of self-assembled materials
robotization ensures that highly reproducible films to be produced, the process beeing automated
salf assembly made of biopolymers (resources from nature)
automatization: enables constant supply
local production is possible
self-assembly process in “green conditions”: does not require solvent (done in aqueous solutions) and works at mild temperatures
- Asia
- Europe
- North America